ViroGates A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VIRO.CO research report →
About the company
ViroGates A/S is a Danish firm specializing in the creation and commercialization of prognostic diagnostic solutions for the medical field. Its flagship product, suPARnostic, is a blood test designed to quantify the soluble urokinase plasminogen activator receptor (suPAR) protein within a patient's circulatory system. This innovative tool empowers hospital emergency rooms to refine their clinical assessments regarding the admission or release of patients with acute medical conditions, thereby contributing to lower healthcare expenditures.
- CEO
- Jakob Ole Knudsen
- IPO
- 2018
- Employees
- 7
- HQ
- Birkerød, DK
Price Chart
- Market Cap
- $78.90M
- P/E
- -8.23
- P/S
- 9.39
- P/B
- 5.64
- EV/EBITDA
- -5.46
- Div Yield
- 0.00%
- Gross Margin
- 76.92%
- Op Margin
- -133.07%
- Net Margin
- -121.61%
- ROE
- -93.38%
- ROIC
- -48.60%
- Revenue
- $5.31M · 8.37%
- Net Income
- $-10,397,000 · 27.52%
- EPS
- $-1.32 · 38.60%
- Op Income
- $-14,069,000
- FCF YoY
- 65.48%
- 52W High
- $17.40
- 52W Low
- $7.52
- 50D MA
- $10.63
- 200D MA
- $11.93
- Beta
- 0.64
- Avg Volume
- 809
Get TickerSpark's AI analysis on VIRO.CO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VIRO.CO coverage
Recent articles, reports, and earnings notes.
No research on VIRO.CO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VIRO.CO report →Similar companies
Peers in the same neighborhood.